KELLY BULK: Open Payments
NPI 1033144340 · GRANT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,157 in 83 payments from 9 companies in 2025. Trend: 2023 $230 · 2024 $508 · 2025 $1,157
Food & beverage: $1,157
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 19 | $199 |
| Neurocrine BioSciences, Inc. | 15 | $195 |
| Otsuka America Pharmaceutical, Inc. | 9 | $181 |
| ABBVIE INC. | 17 | $179 |
| Axsome Therapeutics, Inc. | 8 | $121 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $83 |
| Teva Pharmaceuticals USA, Inc. | 4 | $75 |
| Supernus Pharmaceuticals, Inc. | 4 | $61 |
| Lundbeck LLC | 3 | $61 |
Products named: REXULTI, FANAPT, INGREZZA, VRAYLAR, Auvelity, CAPLYTA, AUSTEDO XR, Qelbree.
Industry payments across MI — which companies pay providers there.
